The World Health Organisation (WHO) and its sister agencies have raised concerns over interruptions in the supply of internationally controlled medicines due to Covid-19 pandemic.
WHO, International Narcotics Control Board (INCB) and the United Nations Office on Drugs and Crime (UNODC) has called on governments to ensure that the procurement and supply of controlled medicines in countries meet the needs of patients.